Investor Presentation - First Nine Months of 2016 slide image

Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Slide 89 Haemophilia is a rare disease with severe unmet medical needs Number of people with haemophilia A and B and haemophilia with inhibitors Low diagnosis and treatment rates within haemophilia Average percentage of people with haemophilia Number of people (000) 500 Haemophilia A Haemophilia B 400 App. 350,000 patients App. 70,000 patients 300 45% Inhibitor segment app. 3,500-4,000 patients 200 100 15% 6% 3% 0 People with haemophilia Diagnosed Treated Prophylactic Pristine joints Note: The inhibitor segment represents people with haemophilia and high titre inhibitors to their normal replacement treatment Source: Estimates based on prevalence data in literature (Stonebraker JS et al. Haemophilia. 2010; 16: 20-32), World Federation of Haemophilia - Annual Global Survey 2012, UDC database in the US changing diabetes® Source: World Federation of Haemophilia - Annual Global Survey 2012 novo nordisk
View entire presentation